Rokit Healthcare Highlights The Business Research Company's Chronic Kidney Disease Market
On April 15, 2025, the report details Rokit Healthcare's upcoming IPO scheduled for May 12, 2025. The company specializes in personalized regenerative medicine using AI-based 3D bioprinting technologies. With operations in 46 countries, it projects significant revenue growth and aims to expand globally by 2027

